CClinicalTrials.gg
Status unknownNCT03679988Updated Sep 25, 2018

Prevalence of Oral Mucosal Alterations in Mucocutaneous Ocular Disorders

An observational study in Oral Disease and Muco-Cutaneo-Ocular Syndrome, sponsored by Sherin Alaa Eldin Eisa Elsayed. Status unknown. Per ClinicalTrials.gov, last updated 2018-09-25.

Sponsored by Sherin Alaa Eldin Eisa Elsayed · Observational

The sponsor has not verified this record recently (last verified Sep 2018), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
380
Sex
All
01

Study summary

The patients will be selected from the pool of the Clinics (Rheumatology, Ophthalmology and Dermatology) of Faculty of Medicine and (Diagnostic center and Oral Medicine) of Faculty of Dentistry -Cairo University. For each eligible participant, a full history will be obtained followed by thorough clinical examination.

02

Conditions studied

  • Oral Disease
  • Muco-Cutaneo-Ocular Syndrome

Browse trials for

Keywords

  • oral health status
  • oral findings
  • oral manifestations
  • patient with mucocutaneous ocular disorders
  • mucocutaneous ocular disorders
03

In context

Mouth Diseases

109 studies on the registry are indexed under Mouth Diseases; 18 are open to participants now.

This study's planned enrollment of 380 is above the median of 180 across 27 observational studies indexed under Mouth Diseases.

Browse Mouth Diseases studies →

Lead sponsor

This is the only study on the registry with Sherin Alaa Eldin Eisa Elsayed as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Sampling method
Non-probability sample

Study population

A convenience sample of adult patients diagnosed with mucocutanous oculer disorders attending to Clinics (Rheumatology, Ophthalmology and Dermatology) of Faculty of Medicine and (Diagnostic center and Oral Medicine) of Faculty of Dentistry -Cairo University will be enrolled in the study in a consecutive order.

Inclusion criteria

  • Adult patients diagnosed with one of the mucocutaneous disorder.
  • Patient who will agree to participate in the study.
  • Patients who will accept to sign the informed consent.

Exclusion criteria

Exclusion Criteria:

  • Patients not physically able to participate in survey or clinical oral examination.
05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
380 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Identifying and recording oral mucosal alterations

    clinical examination according to World Health Organization guidelines

    Time frame: 10 min

Secondary outcomes

  1. Identifying the oral health-related quality of life: OHIP-14

    using Oral Health Impact Profile-14 (OHIP-14) Slade G. and Spencer A.: Development and evolution of the oral health impact profile. Community Dent Health, 11 (1): 3-11, 1994 Response categories for the five-point scale are: "Very often", "Fairly often", "Occasionally", "Hardly ever" and "Never".

    Time frame: 10 min

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 25, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03679988
Lead sponsor
Sherin Alaa Eldin Eisa Elsayed
Collaborators
Cairo University
Responsible party
Sherin Alaa Eldin Eisa Elsayed (principle investigator , oral medicine department, Cairo University) — Sponsor-investigator
First posted
Sep 21, 2018
Start date
Oct 2018 (estimated)
Primary completion
May 30, 2019 (estimated)
Completion
Aug 2019 (estimated)
Last update
Sep 25, 2018

Study contacts

sherin alaa eldin eisa elsayed, BDS
Contact
dr.sherin.alaa@gmail.com
+201000036620
wessam abd el moneim
Contact
wesammhs@yahoo.com
+201207033303

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion